Question 1

How many shares of BCRX does STIFEL FINANCIAL CORP own?

Accepted Answer

As of 2026-Q1, STIFEL FINANCIAL CORP holds 1.8M shares of BCRX (BIOCRYST PHARMACEUTICALS INC).

Question 2

What is STIFEL FINANCIAL CORP's BCRX position worth?

Accepted Answer

As of 2026-Q1, STIFEL FINANCIAL CORP's BCRX position is worth $17.4M.

Question 3

Is STIFEL FINANCIAL CORP buying or selling BCRX?

Accepted Answer

In 2026-Q1, STIFEL FINANCIAL CORP increased their BCRX position (+0.0% change in shares).

Question 4

When did STIFEL FINANCIAL CORP first buy BCRX?

Accepted Answer

Based on available 13F filings, STIFEL FINANCIAL CORP first reported a position in BCRX in 2024-Q2. They have held the position across 25 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Increased	1.8M	+0.0%	$17.4M	0.0%	$8.69	28
2025-Q4	Increased	1.8M	+0.1%	$14.2M	0.0%	$7.66	28
2025-Q3	Decreased	1.8M	-0.0%	$13.8M	0.0%	$7.55	0
2025-Q2	Decreased	1.8M	-0.8%	$16.3M	0.0%	$9.36	0
2025-Q1	Decreased	1.8M	-0.3%	$13.8M	0.0%	$7.86	0
2024-Q4	Decreased	1.8M	-0.0%	$13.9M	0.0%	$7.53	0
2024-Q3	Decreased	1.8M	-0.0%	$14M	0.0%	$7.62	0
2024-Q2	Decreased	1.8M	-0.0%	$11.4M	0.0%	$6.18	0